Skip to main content

News Archive

News Archive - Yadira Galindo

Clinical Trial Tests Tattoo Sensor as Needleless Glucose Monitor for Diabetes Patients

April 19, 2018

For Angela Valdez, being diagnosed with diabetes was an awakening. The disorder ran in her family, but she didn't think it would happen to her. And when it did, she acted by modifying her diet and physical activity. She was doing everything right - almost.

Receptivity to E-cigarette Ads among Young Adults in the U.S. Leads to Cigarette Smoking

March 26, 2018

Receptivity to advertising for e-cigarettes, cigarettes and cigars were confirmed to be associated with those who would try the respective tobacco product within one year. However, receptivity to e-cigarette advertising also independently increased the odds that 12- to 21-year-olds who have never smoked would try cigarette smoking within the next year by 60 percent. This finding, publishing in the March 26 issue of JAMA Pediatrics, was independent of receptivity to cigarette advertising.

Beneficial Skin Bacteria Protect Against Skin Cancer

February 28, 2018

Science continues to peel away layers of the skin microbiome to reveal its protective properties. In a study published in Science Advances on February 28, University of California San Diego School of Medicine researchers report a potential new role for some bacteria on the skin: protecting against cancer.

Enzyme Plays a Key Role in Calories Burned both During Obesity and Dieting

February 8, 2018

Ever wonder why obese bodies burn less calories or why dieting often leads to a plateau in weight loss? In both cases the body is trying to defend its weight by regulating energy expenditure. In a paper publishing in Cell on February 8, University of California San Diego School of Medicine researchers identify the enzyme TANK-binding kinase 1 (TBK1) as a key player in the control of energy expenditure during both obesity and fasting.

Peptide Improves Glucose and Insulin Sensitivity, Lowers Weight in Mice

February 7, 2018

Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School of Medicine researchers.

UC San Diego Health and Eisenhower Health Affiliation Expands Cancer Services in Coachella Valley

January 11, 2018

UC San Diego Health and Eisenhower Health signed a five-year affiliation agreement to expand cancer services for residents of Coachella Valley. Starting in January 2018, as a member of the UC San Diego Health Cancer Network, patients of Eisenhower Health will have enhanced access to world-class cancer care, both at Eisenhower Lucy Curci Cancer Center and at UC San Diego Health.

Study: Medications Alone Don’t Help Smokers Quit

December 20, 2017

Pharmaceutical interventions are routinely prescribed to help people quit smoking. However, a new study by University of California San Diego School of Medicine researchers suggests that, despite promising results in clinical trials, smoking cessation drugs alone may not be improving the chances of successful quitting among smokers in general.

Plain Cigarette Packaging May Reduce Incorrect Impression of Product’s Safety

December 18, 2017

An online survey of 900 consumers of three of the United States’ most popular cigarette brands suggests that adopting standardized cigarette packing may reduce consumers’ misconceptions that some cigarettes are less harmful than others, reports a team of researchers led by University of California San Diego School of Medicine and published in BMJ Tobacco Control.

Drug Suppresses Spread of Breast Cancer Caused by Stem-like Cells

December 11, 2017

Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report University of California San Diego School of Medicine and Moores Cancer Center researchers.

Vulnerability Identified for Subtypes of Glioblastoma

November 30, 2017

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically distinct subpopulation of patients with glioblastoma that is particularly sensitive to drugs like cilengitide that target a cell adhesion receptor known as integrin αvβ3.
Category navigation with Social links